1 suspended. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
| Phase 2 | 1 | Suspended 1 |
Follow Diffuse Large B-Cell Lymphoma Unclassifiable: new trials by email Literature Review of Diffuse Large B-Cell Lymphoma Unclassifiable trials Research Report on Diffuse Large B-Cell Lymphoma Unclassifiable
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma Cyclophosphamide, Doxorubicin Hydrochloride, Nivolumab - Aggressive Non-Hodgkin Lymphoma, B-Cell Non-Hodgkin Lymphoma | Phase 1 / Phase 2 | Suspended | Northwestern University | 30 | 2018-11-20 | 2022-08-15 |
Lymphoma, B-Cell (1)
Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Lymphatic Diseases (1) · Lymphoma (1) · Lymphoma, Non-Hodgkin (1) · Lymphoproliferative Disorders (1) · Neoplasms (1) · Neoplasms by Histologic Type (1)
CT-P10 (1) · Cyclophosphamide (1) · Doxorubicin (1) · Nivolumab (1) · Prednisone (1) · Rituximab (1) · Vincristine (1) · deltacortene (1) · prednylidene (1)
United States (1)
Reem Karmali, MD (1)
P30CA060553 (1)